Leonite Capital LLC's Form 4 filing
Pasithea Therapeutics Corp.KTTA · filed Aug 26, 2022
- Accession no.
- 0001209191-22-047714
- Filed
- Aug 26, 2022, 4:30 PM ET
- Trade date
- Aug 19, 2022
- Filing delay
- 7 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $70.9K. It was filed 7 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Leonite Capital LLCCIK 0001824520 | Other: Member of 10% owner group |
| Geller AviCIK 0001883076 | Other: Member of 10% owner group |
| Leonite Fund I, LPCIK 0001944053 | Other: Member of 10% owner group |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 19, 2022 | Common Stock | PPurchaseAcquired | +54,644 | $1.30 | +$70,938.84 | 54,644 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.